爱美客(300896.SZ)：子公司取得米诺地尔搽剂《药品注册证书》

Core Viewpoint - The company, Aimeike (300896.SZ), announced that its wholly-owned subsidiary, Beijing Nobot Biotechnology Co., Ltd., has received approval from the National Medical Products Administration for the registration of Minoxidil topical solution in 2% and 5% concentrations, which are non-prescription dermatological medications [1] Group 1: Product Details - The 2% concentration is intended for the treatment of androgenetic alopecia and alopecia areata [1] - The 5% concentration is restricted for use by males only, also for the treatment of androgenetic alopecia and alopecia areata [1] - Minoxidil is a peripheral vasodilator that, when used topically over a long period, can stimulate hair growth in patients with androgenetic alopecia and alopecia areata [1]